John E. Macor
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (United States)(US)Sanofi (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Synthesis and Biological Evaluation, Neuroscience and Neuropharmacology Research, Synthesis and Reactions of Organic Compounds, Chemical Reaction Mechanisms
Most-Cited Works
- → Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor(2010)184 cited
- → 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1*) agonist and rotationally restricted phenolic analog of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole(1990)160 cited
- → The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist(2001)158 cited
- Annual Reports in Medicinal Chemistry(2002)
- → (−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘-oxazolidin-2‘-one], a Conformationally Restricted Analogue of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor(2000)132 cited
- → Enantioselective Synthesis of a Highly Potent Selective Serotonin Reuptake Inhibitor. An Application of Imidazolidinone Catalysis to the Alkylation of Indoles with an α,β-Disubstituted α,β-Unsaturated Aldehyde(2005)123 cited